SCHEMBL6027150

SCHEMBL6027150

CC1CCCCC1C(=O)Nc1ccc(-c2ncc(-c3ccccc3NC3C4CC5CC(C4)CC3C5)[nH]2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.43
RAB9A P51151 6/20 0.38
NPC1 O15118 4/20 0.38
MAPT P10636 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HPGD P15428 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.35
SCN3A Q9NY46 2/20 0.33
GAA P10253 2/20 0.33
SCN9A Q15858 1/20 0.33
ROCK1 Q13464 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
ALDH1A1 P00352 4/20 0.32
MAPK1 P28482 1/20 0.32
GFER P55789 1/20 0.32
KDM4E B2RXH2 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6887943 0.90 RAB9A (0.38) BRD4RAB9ANPC1MAPTMEN1
SCHEMBL6027185 0.88 PTPN1 (0.44) BRD4RAB9ANPC1MAPTKMT2A
SCHEMBL6026610 0.87 BRD4 (0.44) BRD4RAB9ANPC1MAPTMEN1
SCHEMBL6026685 0.81 PTPN1 (0.44) BRD4RAB9ANPC1MAPTKMT2A
SCHEMBL6887912 0.80 NPSR1 (0.45) BRD4RAB9ANPC1MEN1KMT2A
SCHEMBL6027333 0.80 BRD4 (0.42) BRD4RAB9ANPC1MAPTMEN1
SCHEMBL6888532 0.77 MAPT (0.37) BRD4RAB9ANPC1MAPTMEN1
SCHEMBL6885880 0.76 SCN3A (0.42) RAB9ANPC1MAPTMEN1KMT2A
SCHEMBL6027147 0.76 SCN3A (0.39) RAB9ANPC1MAPTMEN1KMT2A
SCHEMBL6030700 0.76 PTPN1 (0.51) RAB9ANPC1HPGDSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613310-A1 IMIDAZOLE DERIVATIVES FOR TREATMENT OF ALLERGIC AND HYPERPROLIFERATIVE DISORDERS Avanir Pharmaceuticals (US) 2006-01-11 EP disclosed
WO-2004091610-A1 IMIDAZOLE DERIVATIVES FOR TREATMENT OF ALLERGIC AND HYPERPROLIFERATIVE DISORDERS AVANIR PHARMACEUTICALS (US) 2004-10-28 WO disclosed